Induced pluripotent stem-cell-derived hepatocytes engineered to contain FLAG-tagged, doxycycline-inducible IFNLR1 isoform constructs were HBV-infected and then treated with IFNL3 followed by assessment of gene expression, HBV replication, and cellular viability.
[Antiviral Research]